On his latest interview, European Vaccine Initiative's executive director, Ole Olesen, shares his experience during the first nine months in the job grappling with a global pandemic; EVI's mission to support the development of non-commercially viable vaccines and the establishment of a sustainable European vaccine infrastructure, as well as his hopes for the future of the vaccine sector.
Read the full article at PharmaBoardroom:
